What AI says about Anima Biotech

AnimaBiotech offers an AI-driven drug discovery platform called BioGPU, a Visual Biology Computing stack that enables AI models to reason directly inside cells by visually computing biological pathways and mechanisms in action at AI scale. The platform includes a Visual Biology Model trained on over 2 billion pathway images, a large-scale Experimental Biology Runtime, and a BioGPU Agent that connects LLMs to the infrastructure to deliver an explainable, causal reasoning loop grounded in real biology. It supports end-to-end discovery—from identifying disease-driving pathways and targets to hit identification, lead optimization, and preclinical evaluation—with private-cloud deployment and partnerships to build an AI-to-cell discovery stack.